Ireland
--:--IST
Active, not recruiting Not applicable

The Coastal Exposome: a Study of Sea Air Inhalation and Possible Links to Health

NCT06477627 · tracked via the Priya Life Science Belgium tracker
Phase
Not applicable
Started
2024-06-19
Last updated
2026-06-03

Condition(s) studied

Difference Between Coastal and Inland Populations

Investigational drug(s) / intervention(s)

no intervention

no intervention: no intervention, people just indicate if they spend time inland or at the coast

Study summary

The research aims to understand oceans as crucial contributors to human health in coastal environments. Oceans produce marine spray aerosols that contain a mixture of microbiota and natural biological molecules (biogenics).

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * healthy participants between 18 and 50 years old Exclusion Criteria: * people with a medical condition * people younger than 18 and older than 50

Primary outcome measure(s)

  • nose swabs: respiratory microbiome and biogenics profile — 4 times during the 8 week study period
    DNA from the nose swabs will be analysed using sequencing for analyzing the microbiome. Biogenics on the swabs will be analysed as well, to get an idea of what molecules and microbiota from the sea air are inhaled. This will happen with UPLC-QTOF-MS.
  • VAMS blood samples: cytokines — 4 times during the 8 week study period
    Cytokines will be measured in blood samples to link the sea air exposure to the human health. A multiplex kit will be used to measure 20 cytokines.
  • GPS — during the 8 week study period, if more than 15 minutes spend outside
    via sensorlogger app on their phone, to collect GPS data when outside.
  • questionnaires — at the start, in the middle and at the end of the 8 weeks.
    Filling in a questionnaire via qualtrics

Trial sites (1)

FacilityCityRegionStatus
Ghent University Ghent Oost-Vlaanderen
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06477627 on ClinicalTrials.gov ↗ ← All trials in Belgium